Sort
46,585 grants matching “heart failure”
Alabama-Clinical Trials Unit
$2,421,303Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2007 · AI
Integrated Mechanisms of Cardiac Maladaptation
$2,418,248R John Solaro · University Of Illinois At Chicago · P01 · FY2010 · HL
Genetic insights into cardiovascular function and disease
$2,414,057Paul M Hwang · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
$2,413,030Henry M Colecraft · Columbia University Health Sciences · P01 · FY2023 · HL
A Regenerative Approach to Cardiac Pacing
$2,410,000Vasanth Vedantham · University Of California, San Francisco · DP2 · FY2019 · HL
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
$2,409,769Roberta A. Gottlieb · Cedars-Sinai Medical Center · P01 · FY2014 · HL
CaMKII and IP3-Mediated Signaling in Cardiac Myocytes
$2,406,469Donald M Bers · University Of California At Davis · P01 · FY2010 · HL
The ISCHEMIA-CKD Trial-CCC-Lead Application
$2,406,245Sripal Bangalore · New York University School Of Medicine · U01 · FY2017 · HL
Expression, Structure/function, Regulation, and Roles of PDE3 Isoforms
$2,405,695Vincent Manganiello · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
$2,404,471Roberta A. Gottlieb · Cedars-Sinai Medical Center · P01 · FY2015 · HL
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies
$2,401,275Walter J Koch · Temple Univ Of The Commonwealth · P01 · FY2020 · HL
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies
$2,401,275Walter J Koch · Temple Univ Of The Commonwealth · P01 · FY2023 · HL
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies
$2,401,275Walter J Koch · Temple Univ Of The Commonwealth · P01 · FY2022 · HL
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies
$2,401,275Walter J Koch · Temple Univ Of The Commonwealth · P01 · FY2021 · HL
Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia
$2,399,654Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R33 · FY2022 · HL
Building the Chromosome Segregation Machinery from Scratch
$2,399,496Sabine Petry · Princeton University · DP2 · FY2016 · GM
Look AHEAD: Action for Health in Diabetes
$2,397,967Mark Andrew Espeland · Wake Forest University Health Sciences · U01 · FY2009 · DK
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
$2,396,905Henry M Colecraft · Columbia University Health Sciences · P01 · FY2025 · HL
Integrated Mechanisms of Cardiac Maladaptation
$2,396,702R John Solaro · University Of Illinois At Chicago · P01 · FY2012 · HL
Pharmacogenomic Evaluation of Antihypertensive Responses
$2,396,496Julie A. Johnson · University Of Florida · U01 · FY2007 · GM
Cavopulmonary Assist to Reverse the Fontan
$2,396,491Mark D Rodefeld · Indiana University Indianapolis · R01 · FY2020 · HL
Using Genetics For Early Phenotyping & Prevention of Hypertrophic Cardiomyopathy
$2,395,197Carolyn Y Ho · Brigham And Women'S Hospital · P50 · FY2012 · HL
TAS::75 0872::TAS ARIC CLINICAL EXAMINATION CENTER
$2,394,706Gerardo Heiss · Univ Of North Carolina Chapel Hill · N01 · FY2011 · HL
Rare variants and NHLBI traits in deeply phenotyped cohorts
$2,394,488Bruce M Psaty · University Of Washington · R01 · FY2015 · HL
PREVENTABLE Trial Implementation Phase
$2,393,279Karen P Alexander · Duke University · U19 · FY2024 · AG